Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amgen Q2 2024 Adj. EPS $4.97 Misses $5.01 Estimate, Sales $8.388B Beat $8.333B Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:02pm
Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.97 per share which missed the analyst consensus estimate of $5.01 by 0.8 percent. The company reported quarterly sales of $8.388 billion which beat the analyst consensus estimate of $8.333 billion by 0.65 percent. This is a 20.07 percent increase over sales of $6.986 billion the same period last year.

Posted In: AMGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist